More on: Pathogenic antibodies to coagulation factors. Part II: Fibrinogen, prothrombin, thrombin, factor V, factor XI, factor XII, factor XIII, protein C and von Willebrand factor.
作者信息
Jones D W, Gallimore M J, Winter M
出版信息
J Thromb Haemost. 2006 Jan;4(1):282-4. doi: 10.1111/j.1538-7836.2005.01712.x.
Abstract
摘要
相似文献
1
More on: Pathogenic antibodies to coagulation factors. Part II: Fibrinogen, prothrombin, thrombin, factor V, factor XI, factor XII, factor XIII, protein C and von Willebrand factor.更多内容：凝血因子的致病性抗体。第二部分：纤维蛋白原、凝血酶原、凝血酶、因子V、因子XI、因子XII、因子XIII、蛋白C和血管性血友病因子。
J Thromb Haemost. 2006 Jan;4(1):282-4. doi: 10.1111/j.1538-7836.2005.01712.x.
2
Pathogenic antibodies to coagulation factors. Part II. Fibrinogen, prothrombin, thrombin, factor V, factor XI, factor XII, factor XIII, the protein C system and von Willebrand factor.凝血因子的致病性抗体。第二部分。纤维蛋白原、凝血酶原、凝血酶、因子V、因子XI、因子XII、因子XIII、蛋白C系统和血管性血友病因子。
J Thromb Haemost. 2005 Jul;3(7):1385-91. doi: 10.1111/j.1538-7836.2005.01228.x.
3
[Circulating anticoagulants. Clinical conditions of diagnosis].[循环抗凝物质。诊断的临床情况]
Rev Med Interne. 1985 Dec;6(5):523-41. doi: 10.1016/s0248-8663(85)80035-7.
4
The normal coagulation mechanism.正常凝血机制。
Med Clin North Am. 1972 Jan;56(1):95-104. doi: 10.1016/s0025-7125(16)32425-7.
5
The mechanism of blood coagulation.血液凝固的机制。
Ergeb Physiol. 1973;68:1-53. doi: 10.1007/3-540-06238-6_4.
6
[The physiology of blood platelets].[血小板的生理学]
Schweiz Med Wochenschr. 1968 Oct 19;98(42):1629-35.
7
The chemistry of blood coagulation.血液凝固的化学过程。
Clin Haematol. 1979 Feb;8(1):3-30.
8
Relationships between platelets and coagulation factors in hemostasis.止血过程中血小板与凝血因子之间的关系。
Annu Rev Med. 1978;29:41-9. doi: 10.1146/annurev.me.29.020178.000353.
9
[Influence of pregnancy on the activation factors of blood coagulation and on thrombocytes].[妊娠对血液凝固激活因子及血小板的影响]
Z Geburtshilfe Perinatol. 1972 Jun;176(3):183-92.
10
Therapeutic materials used in the treatment of coagulation defects.用于治疗凝血缺陷的治疗材料。
Clin Haematol. 1979 Feb;8(1):183-206.
引用本文的文献
1
Clinical association between pre-treatment levels of plasma fibrinogen and bone metastatic burden in newly diagnosed prostate cancer patients.初诊前列腺癌患者治疗前血浆纤维蛋白原水平与骨转移负荷的临床相关性。
Chin Med J (Engl). 2019 Nov 20;132(22):2684-2689. doi: 10.1097/CM9.0000000000000506.
Zotero 插件